The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
Is it time to change our relationship to NSAIDs, like Advil? What are the alternatives?
The latest trends in the ongoing battle over liability in America’s opioid abuse epidemic.
Movement therapies have innumerable benefits on their own. Here’s how they are helping in the fight against the opioid epidemic.
When Max Tillitt succumbed to opioid addiction, his mother took their insurance to court after it allegedly cut Tillitt’s recovery funds short.
At RIMS 2022, Dorothy Riviere, chief clinical officer of Bardavon Health, spoke about PT and pain management, and the need to better educate injured workers.
The big pharmacies in the U.S. are next in line for opioid crisis scrutiny as more and more states sue responsible parties.
Amazon to pay $2.25 million and cease “Sold by Amazon” operations after Washington state AG files antitrust suit accusing the online retailer of price fixing.
Physical therapy and pain management intervention proved productive in replacing opioids as methods to control pain in injured workers.
The latest court filings and cases that will have an impact on the risk management and insurance industry.
Johnson & Johnson, Cardinal Health, AmerisourceBergen and McKesson have reached a $26 billion deal with state attorneys general that would release them from all civil liability in the opioid epidemic.
When Purdue Pharma was first sussed out as a leading cause of the opioid epidemic in the U.S., it wouldn’t be long until the pharmaceutical company’s partners were feeling the heat.
The opioid misuse crisis continues to negatively impact the lives of patients while costing our health care system billions of dollars. This is why it still deserves our focus.
Join myMatrixx’s Phil Walls and The Hartford’s Adam Seidner as they explore alternative approaches to opioid pain management in workers’ compensation claims.
A CompTalk presented by the National Comp Conference dives into fentanyl’s transformation into one of the deadliest opioids in today’s epidemic.
A new report concluded that COVID-19 has led to increased opioid abuse, medical marijuana legislation and drugs delivered by mail.
Unaddressed behavioral health factors can drive up costs for payers and expose injured workers to delayed return-to-work and painkiller addiction.
Despite regulation meant to curb abuse of physician dispensing, it’s still a common practice and presents both safety and financial risks.
The N.Y. DFS files charges against Teva Pharmaceuticals and Allergan for insurance fraud in connection to the state’s opioid crisis.